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Íummory
[hopler I darcriber the oim of
lha rludy
l nabout  ha l f  o f  the  pa t ien ts  who undergo (success fu l )
surgical  t reatment for  colorectal  cancer,  metastases
io the l iver are encountered ur ing or af ter  the opera-
t ion Appl icat ion of  external  radiotherapy or chemo,
therapy only has a pal l iat ive f iect ,  mainly due to the
restr ict ions of  s ide ef fects.  Newer therapies,  such as
cryosurgery and brachytherapy, are of ten appl ied to
inoperab le  m tas tases  and they  appear  to  have a  fa
vourable ef fect  on survival  At  present,  var ious t reat-
ment  op t ions  are  rece iv ing  cons idera t ion ,  such as  ra -
diofreq uency a blat ion,  laser- i  nd u ced thermothera py,
gene therapy  and monoc lona l  an t ibod ies  w i th  o r
without radioact ive la bel  I  i  ng
The oniy t reatment for  metastases to the l iver that
has  any  chance o f  cur ing  the  pa t ien t  i s  surg ica l  re -
sect ion.  About 3ooro of  the pat ients wi th metastases
are l igrble for  surgical  t reatment.  Five-year survival  in
these pat ients is 3o-4ool0.  In many of  the pat lents who
are candidates for  surgical  resect ion of  the rnetas-
tases, i t  is  d i f f icul t  o achieve completely tumour-free
exc is ion  marg ins .These pa t ien ts  have the  h ighes t  r i sk
o f  tumour  ecur [ence in  the  l i ver .
With the aid of  radrotherapy, r t  is  possible to f ight  the
tumour t issue that is lef t  in s i tu at  the surgical  mar
g ins .  Ex terna l  rad io therapy  is labor ious  owing  to  the
h igh  r ísk  o f  rad ia t ion  darnage to  the  l Í ver  and o ther
sensi t rve t issues in the region of  the l iver,  such as the
ntest ines.  Intraoperat ive radiotherapy ( IORT) com
prrses  the  r r rad ia t ion  o f  the  surg ica l  marg ins  w i th  a
s ing le  h igh  dose o f  rad ia t ion  d i rec t l y  fo l low ing  tu -
mour excisÍon. The great advantage of  IORT is that
the radiat ion dose can be grven at  precisely the de
s i red  loca t ion ,  wh i le  sh ie ld ing  any  ad jacent  sens i t i ve
SITUCIU TES.
Present ly,  i t  is  not  c lear how l iver t issue reacts to a
s ing le  h igh  dose o f  rad ia t ion .  l t i s  obv ious ly  no t  the
in ten t ion  to ser ious ly  damage the  remain ing  l i ver
t issue orcause heal ing def ic i ts or abscess format ion
that would threaten organ funct ion.
Th is  thes is  descr ibes  an  an imal  s tudy  on  the  dam-
age that occurs af ter  a s ingle high dose of  radiat ion
to  normal  l i ve r  t i ssue and surg ica l l y  man ipu la ted  l i ver
t issue. The animal model used appeared to be sui t -
ab le  fo r  t rans la t ion  to the  human s r tua t ion .
[hopler 2 darcriber lheboric
principler of rodiobiology
The ef íect  of  exposure to radiat ion depends on the
type of  radiat ion ( in th is study: electrons) and the
energy .  Dur ing  the  app l ica t ion  o f  rad io therapy ,  i t  i s
necessary to f ind a balance between f ight ing the
tumour  and caus ing  as  l i t t le  damage as  poss ib le  to
the heal thy t issues. Each t issue type reacts di f ferent ly
to radiotherapy. Inthe case of  heal thy t issues, the res-
ponse depends s t rong ly  on  the  ra te  o f  ce l l  d iv is ion .
The fas te r  a ce l l  d iv ides ,  the  grea ter  i t s  rad iosens i t i v i t y
The type o f  t i ssue a lso  p lays  an  impor tan t  ro le  and
th is  ch ie f l y  concerns  t i ssue func t ion  ( read:  o rgan) .  In
addi t ion,  at tent ion should be paid to the exposure
vo lume:  i f  even a  very  smal l  par t  o f  the  sp ina l  cord  is
i r radiated, total  paralysis can occur.  In contrast ,  paren
chymal  o rgans  uch as  the  l i ver  usua l ly  have su f Íc ien t
remaining capaci ty.  However,  radiotherapy af ter  sur-
g i c a l  r e s e c t i o n  m i g h t  r e d u c e  t h e  r e m a i n i n g  c a p a c i t y
d rast ica l ly .
Character ist ic di f ferences in radiosensi t iv i ty exist
be tween normal  t i ssue and tumour  t i ssue.  RadÍob i -
ology makes use of  these di f ferences to k i l l  a maxi
m u m  n u m b e r  o f  t u m o u r  c e l l s  w h i l e  c a u s i n g  t h e  l e a s t
poss ib le  damage to  the  hea l thy  t i ssues .  By  d iv id ing
the total  radiat ion dose into smal l  f ract ions ( f ract iona-
t Íon)  and by  app ly ing  the  f rac t Íons  over  a  number  o f
weeks ,  the  h ighes t  poss ib le  dose can be  g iven w i th
the  smal les t  poss ib le  damage to  hea l thy  t i ssues .  Ow-
ing to the fact  that  the IORT treatment f ie ld does not
inc lude hea l thy  t i ssues ,  a  h igh  dose can be  g iven in
one sess ion .
The l i ver  i s  composed o f  connect ive  t i ssue,  b lood
vesse ls ,  b i le  duc ts  and spec ia l i sed  cc l l s  (hepatocy tes)
tha t  a re  respons ib le  fo r  e .g .  remov ing  waste  produc ts
from the blood and excret ing them from the body in
the form of bi le v ia the intest ines.  Al l  these structures
have the i r  own ind iv idua l  rad iosens i t i v i t y .  Hepato-
cy tes  can be  k i l led  d Í rec t l y  by  i r rad ia t ion ,  o r they  can
d ie  dur ing  ce l l  d iv is ion ,  o r  d ie  ind i rec t l y  a t  a  la te r  da te
as  a  resu l t  o f  damage to  the  connect ive  t i ssue and
blood vessels.  Part icular ly regarding the late ef fects
o f  rad ia t ion  damage,  i t  i s  unc lear  what  the  in f luence
is  o f  the  s ing le  h igh  dose used in  th is  s tudy .
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In Chopter 3 the development ond opplicotion of l0[lT ore dercribed
IORT is  the  app l ica t ion  o f  a  s ing le  h igh
dose of  (e lectron) radiat ion to an oper
a t ive ly  exposed tumour  o r  the  surg ica l
marg ins  a f te r  tumour  resec t ion  dur ing
an e lec t i ve  surg ica l  p rocedure .
Al though the biological  ef fect iveness
(RBE)  o f  a  s ing le  does  is  g rea ter  than
that of  f ract ionated therapy, the advan-
tages of  IORT are not so much based on
rad iob io log ica l  p r inc ip les  (see Chapter
z )  as  on  phys ica l  p r inc ip les :  the  i r radra-
t ion  can be  app l ied  very  accura te ly  and
hea l thy  t i ssues  can be  exc luded f rom
the t rea tment  f ie ld .
IORT can a lso  p lay  a  ro le  in  the  t rea t -
ment  o f  tumour  recur rence a f te r  con-
vent ional  radiotherapy, because IORT
spares  ear l ie r  i r rad ia ted  normal  t i ssues .
ln t9o7, D years af ter  the discovery of
X-rays,  the f i rst  descr ipt ion of  IORT was
pub l ished in  connect ion  w i th  an  inop-
erab le  s tomach tumour .  A  h is to r ica l
overview is given of  the development
of  radiotherapy from the f i rst  reatment
for skin diseases with X-rays,  to the cur-
ren t  w ide- rang ing  app l ica t ions ,  uch
as external  radiotherapy with 3-dimen-
s iona l  p lann ing ,  b rachy therapy ,  rad io -
ac t ive  labe l led  an t ibod ies  and IORT.  l t
sneaks  fo r  i t se l f  tha t  the  resu l ts  o f  an i -
ma l  exper iments  and c l in ica l  s tud ies  in
combina t ion  w i th  rap id  techno log ica l
progress have increased the capaci ty of
r , a d i n ï h c r , a n \ /  o \ / Ê r  ï h p  n , r c . ï  1 n n  \ / ê r r q
' L ' u Y , y  v v L r  L r  r !  
v u J L  r v v  / L u r J .
l n  the  per iod  f rom :964 to  1976,  the
f i rst  c l in ical  studies were performed in
Japan on pat ients t reated with IORT.
Soon af terwards, studies were per
fo rmed in  the  US,  Spa in  and Germany.
S i n c e  t 9 8 6 , I O R T  h a s  b e e n  u s e d  i n  c l i n i -
ca l  s tud ies  in  the  Nether lands  (Gron in -
gen,  E indhoven)  ma in ly  fo r  co lo rec ta l
cancer .  In  many cases ,  a combina t ion
of surgery,  external  radiotherapy and
IORT was used.
These c l in ica l  s tud ies  were  preceded by
ó v t ó n c i r r n  r n i m r l  h ^c x L r r  r 5 r v r  d r  i l Í r  r d r  e X p e f  l m e n l S  O t ' l  I  r  r c
sens i t i v i t y  o f  var ious  t i ssues  and organs
to  a  s rng le  h igh  dose o f  rad io therapy .
The dog proved to  be  a  re l iab le  and comparab le  an ima l  mode l  to  t rans la te  he
resu l ts  to  the  human s i tua t ion .
At present,  IORT is being appl ied to e.g.  gastrointest inal  tumours,  breast cancer,
sarcomas,  pancreat ic  and b i l ia ry  tumours  and head and neck  tumours .  A l though
var ious studies have indicated a posi t ive ef fect  on survival  in gastrointest inal
cancer pat ients,  s imi lar  ef fects have not yet  been proven at  other locat ions.Wel l -
known problems are the di f f icul ty of  set t ing up prospect ive randomised tr ia ls and
the need for mult icentre studies:  only a few centres are able to apply IORT, owing
to the need for large infrastructural  investments.
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livar metollorer
The only t reatment for  l iver metastases that has a
chance o f  cur ing  the  pa t ien t  i s  surg ica l  resec t ion .
Increas ing  exper ience and improved iagnos t ics ,  in -
^ i - ^ + i ^ ^ '  ' '  ' ' ^ ;  ^ - l  t p r ^ h n i a r r e s  . r n d  n p r i o n c r , a ï i t r p  r a r pU I L O L I ( J I  l ) /  ) U I 9 l L d l  r L L r  i l  i l g u L )  o t r L r  p - ,
have resulted in a 5-year survival rate of 21 lo 480k,
Nevertheless only 25o/o f  pat ients wi th l iver netas-
t1 '  ^ '  1r^ - '  ' i t 'Ár^ candidates for  suroical  t reatrnent.L O ) C )  d  I  C  ) U  r r d  U r r -  L d  I  r u  t u  t c >  t u t  > u  
-
Patient select ion is extremelv imoortant in the deci-
s ion of  whether or not to perform surgical  excis ion f
l ; , , ^ .  - ^ r ^ - + 1 - ^ -
r v E r  r  r c L d ) L d > u ) .
Prognost ic factors in the surgical  t reatment for  l iver
metastases chief ly concern:  number and size of  the
metastases, metastases outside the l iver and the
wid th  o f  the  tumour - f ree  surg ica l  marg ins .
Treatment for l iver metastases with chemotherapy,
whether or not in combinat ion wi th other t reat-
ment forms, st i l l  only has a pal l iat ive f fect .  Studies
on di f ferent combinat ions of  ant i tumour therapies
appl ied according to di f [erent protocols howed no
more  than s l igh t  improvement  in  surv iva l .One o f  the
l imit ing factors was the severe s ide-ef fects of  chemo-
therapy for the pat ient .  Exper imental  techniques for
the  admin is t ra t ion  o f an t i tumour  med ica t ion ,  such
as isolated l iver perfusion or label led ant ibodies,  may
he ln  to  so lve  th is  o rob lem.
Tai lored i rect  reatment for  metastases, such as f reez-
ing (cryotherapy) or destroying them by means of
ment for colorectol
[hopter 4 dercriber the curren+ treot-
Summary rex
heat (radiofrequency ablation and laser-induced thermotheíapy), seems to have a íavourable effect on inoperable metas-
tases, although at present there are insuffcient data.
Despite improved techniques, conventional radiotherapy in the form of external irradiation only has palliative value owing
to the high risk of damage to normal tissues. Other treatment strategies that make use of radiation are currently under study.
These include remote afterloading interstitial (1r 92) radiotherapy, radioactive implants, the use of radioactive labelled anti-
bodies and selective embolisation by means of radioactive colloids.
[hopfer 5 giver 0n overview of currenl knowledge on rodiotion domoge to fhe liver.
Animal  s tud ies  and c l in ica l  s tud ies  have shown tha t  the  rad iosens i t i v i t y  o f  the  l i ver  var ies  depend ing  on  the  phys ica l  pa-
rameters of  the radiat ion,  such as type of  i r radiat ion,  dose, f ract ionat ion and treatment volume. In addi t ion,  the physical
( t . r ï .<.  of  the n.at ioqI  and his/her I iver are of  importance.The use of  toxic medicat ion and surgery to the I iver lead to greater
radlosenstt tvt ty.
ln pat ients,  radiat ion damage is chief ly expressed in a speci f ic  type of  l iver inf lammation that can recover or ul t imately cause
organ fai lure.  General ly,  i t  can be concluded that f ract ionated radiotherapy (maximal :  Gy fract ions) wi th a total  dose of  3o
Gy can be  app l ied  to  the  who le  l i ver  w i thout  any  c lear  func t iona l  damage.
[hopter ó the experimentol [hopter /
onimol model ured in thirludy
Previous t i sue tolerance studies have shown that the
dog as exper imental  n imal is a rel iable model,  because
the technir-al  nrocedure can be translated accrrratelv, . , ' - - '  Y '
to the human si tuat ion owing to the s ize of  the animal.
Structural  and histological  s imi lar i t ies between the ca-
nine i iver and the human l iver mean that the outcomes
of th is study can be used for c l in ical  appl icat ion.
A group of  z5 beagles were div ided into s subgroups
based on the radiat ion dose received. Each animal un-
derwent laparotomy and partial l iver lobe resection
(about 5o/o f the total volume). Haemostasis of the sur-
glcal  margins was achieved using an exper imental tech-
nique with compression st i tches. In the same session,
the surgical  margins and the non-surgical ly manipulat-
ed l iver lobe were i r radiated using a Linear Accelerator
(electron e ergy io MeV) with ro Gy, zo Gy, z5 Gy or 3o
Gy. ln each subgroup, one animal served as a control  by
undergoing the total  surgical  and i r radiat ion procedure
with a dose of  o Gy.The radiat ion was appl ied accurately
to the desired locat ion on the l iver ( the lef t  lobe) using a
soecial t r r l - re f i t t d to the l inear accelerator.  Lead shield-
tng was used to exclude adjacent structures from the
treatrnent volume, e.g.  intest ines and pancreas.
Medical  f i es were kept on the exper imental  n imals
and blood tests were performed regularly.
After 3 months, 1 year, 2years,3 years and s years, ani-
mals were k i l led to obtain macroscopic,  e lectron mi-
croscopic and histopathological  data on the l iver and
aojacent structures.












r  Í  l l
r-yaor ï0ilow-up
The combined surg ica l  and i r rad ia t ion  procedures
were conducted sat isfactor i ly .  Dur ing the fol low-up
per iod of  r  year,  the exper imental  animals survived
the  t rea tment  we l l .  On ly  one an imal  deve loped su-
perf ic ia l  wound infect ion,  which responded to ant i -
b iot ic t reatn ' rent.  Blood tests showed that in the ma-
jo r i t y  o f  an ima ls ,  the  haemoglob in  va lue  decreased
noqtonêrat ivelv hut the values remained within theu L ' v L ' / ,  u ,
normal  range and normal ised  to the  preopera t ive  l -
vels wi th in 3 weeks. Dur ing the f i rst  6 weeks af ter  the
opera t ion ,  a lka l ine  phosphatase inc reased in  some
cases to 1o t i rnes the normal value. This parameter for
hepatocy te  damage was no t  dose-dependent :  the
control  group also showed increased levels.  Within
ó  months ,  the  va lues  had normal ised .  l t  i s  p robab le
that the increases were more the resul t  of  part ia l  iver
resect ion than the radiotherapy No further I iver func-
t ion disturbances were observed.
At  3  months  and a t  1  year ,  one an imal  in  each dos-
age group was k i l led  fo r  eva lua t ion .  l t  appeared tha t
the  resec t ion  marg in  o f  the  l i ver  had adhered to  the
per i toneum and there  was cons iderab le  f ib ros is  (scar
t issue).  Af ter :  months,  the radiotherapy si te showed
a grey area, which under the microscope proved to
be thickening of  the l iver capsule.  Af ter  r  year fo l low-
up, th is was character ised by a local  defect  in the
l i ver  t i ssue in  combina t ion  w i th  severe  f ib ros is .  These












of ro Gy. No abnormal i t ies were
found in  the  o ther  abdomina l  o r -
g a  n s .
H is ropatho log ica l  changes were
present,  such as interst i t ia l  f ibrosis,
hepatocyte atrophy, bl l iary duct
prol i ferat ion and an inf lammatory
react ion of  the parenchyma. These
abnormal i t ies  inc reased w i th  t ime
and with the srze of  the radiat ion
. l ^ - ^ .  - í + ^ .  -  . , ^ - ,oose; al ter  r  year,  only Lhe paren-
chymal inf lammatory react ion had
d isappeared.
lec t ron  mic roscop ic  examrnat ion
after r  year showed interst i t ia l  f ibro-
s is  o f  the  parenchyma jus t  beneath
the  capsu le  and ba l loon-shaped
abnormal hepatocytes in the i r -
radiated area. No relat ion could be
es tab l i shed w i th  the  rad ia t ion  dose
a p p l i e d .
I t  cou ld  be  conc luded tha t  in  th is
an Ímal  mode l ,  in t raopera t ive  ra -
d io therapy  o f  the  l i ver  was  eas i l y
feas ib le  w i thout  any  per ropera t ive
com pl icat ions.  Very l i t t le histological
damage was v is ib le  a f te r  3  months ,
except  fo r  one parenchymal  in f lam-
matory  reac t ion ,  wh ich  sugges led
high resÍstance in the short- term.
However,  af ter  r  year,  severe paren-
chymal  abnormal i t ies  were  found
within the i r radiated area.
Chopler B prerenh lhe rerultr of ,cintigrophy
thol oimad lodelacl ond monilor poribla liver
I00m0ge In 0 nonrnv0five monner
Rad ioact ive tech net iu m-la bel  ed ( isotope: qqmTC) su I  ph u r  col  o id was
in1ected intravenously and absorbed selectrvely by the Kupffer cel Ís.
Any poor ly funct ioning Kupfíer cel ls wi l l  show poor technet ium ab-
sorp t ion .  Graph ic  images o f  the  l i ver  were  ob ta ined us ing  a  gamma
camera. Areas with decreased absorot ion were v is ib le as less intense
areas  on  the  scans  and a  scor rno  svs tem was aoo l ied .  I  i ver  scanswere
performed preoperat ively and at  r ,  3 and o weeks postoperatrvely and
repeated  a t  regu la r  in te rva ls  dur ing  fo l low-up.
The l iver scans were judged for decreased or absent (shr ivel Íed)absorp-
t ion  capac i ty ,  changes in  s rze  (en la rgement )  o f  the  i r rad ia ted  area .
An independent  nuc lear  med ic ine  spec ia l i s t  read the  scans .  The ab-
normal i t ies on the scans were poor ly correlated with the abnormal i t ies
found at  aulopsy Absent or decreased absorpt ion in the long-term
were the only features that appeared to be consistent ly dose-depend-
ent .  Poss ib le  exp lana l  ions  were  tha t  the  ta rge t  a rea  was re la t i ve ly  smal l
compared to the total  volume of  the l iver and the abnormal i t ies were
Iocated in the per iphery.  ln addi t ion,  movement artefacts due to respi-
ra f  ion  may have h indered re l iab le  in te rpre ta t ion .
Chopter 9 prerentr the long-ferm rerulh of lhe rÍudy
Al l  the  exper imenta l  an ima ls  remained in  good phys ica l  cond i t ion
to the end of follow-up. At z years, 3 years and s years after the |ORT
procedure,  the remaining subgroups were ki l led for  h istopathological
evaluat ion.  l t was str ik ing that af ter  2 yeas, the macroscopic defect
was smal le r  and a t  5  years ,  r t  had a lmost  d isappeared.  Mic roscop icex-
aminat ion showed that the th ickening of  the capsule in the short- term
had decreased, but that  the subcapsular f ibrosis had increased. Bi i iary
duct prol i ferat ion and hepatocyte atrophy had decreased. A charac-
ter ist ic f inding was arter io lar  changes, such as endothel ia l  prol i ferat ion
and (af ter  S years)focal  hyal inosis wi th stenosis of  the lumen. Per iportal
f ibrosis that  led to br idging was maximal af ter  z and :  years,  but  had
decreased af ler  5 yedrs.  A c lear border could be dist inguished between
f ibrot ic parenchyma nd normal parenchyma.
After part ia l  l iver resectÍon in th is animal model,  i t  proved to be techni-
cal ly feasible to apply a s ingle high dose of  e lectron radiat ion tothe re-
sect ion margins and to an area of  the normal iver.  Dur ing a fo l low-up
of 5 years,  there were no cases of  t reatment-dependent morbidi tyor
mortal i ty in our exper imental  n imals.  Short- term and long-term radÍa'
t lon damage was considerable.  l t  was in i t ia l ly  expressed in the form of
hepatocyte atrophy and bi l iary duct prol i ferat ion and later expressed
in parenchymal Í rbrosis and af ter  s years,  in portal  vein abnormal i t ies.
In v iew of  the resul ts of  th is study and previous animal exper iments
using IORT, th is animal model seems to be sui table for  t ranslat ion t
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The incidence of  colorectal  carcinoma
is st i l l  increasing. About 5o -  7oo/o of  the
oat ients develoo local  recurrence or' - , " Y
metastases to the l iver and/or lungs.
Dur ing  many years  o f  c l in ica l  app l i ca-
t ion to t reat  local  recurrence, the com-
Ái^ - f  ; ^^  ^ t  - , , " ^ , - ) l  resec t ion  and loRTu i l  r o L r ( J r  |  \ r r  ) u t v t L (
has proved to have favourable resul ts
in  randomised s tud ies .  l t  has  no t  ve t
been clearly estaorisneo *l. in.; icj ' ;
also has favourable f fects on survival
on  o ther  ma l ignanc ies ,  uch  as  pan-
c reas  carc inoma nd gas t r i c  a rc inoma
- l r l ^ , ^ , , ^ Á  l ^ - - l  r , ,ar rnougn rocar  umour  cont ro l  seems
to be imnroved One of  the reasons for
+ Á i .  i .  + l - - r  - - . ] ^ ^ ,  , a r ^  . r ,  , À i ^ .  ^ . ^  l ^ - l , iI n r S  r S  I n a I  a o e q u a r e  s L U U r e s  d r e  r d c K r n 9 .
Poss ib i l i t i es  fo r the  app l ica t ion  o f  IORT
seem to regard the t reatment oí  breast
cancer.  Future t reatment of  breast can-
cer  cou ld  cons is t  o f  lumpectomy and
a sent inel  node procedure fo l lowed
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l ^ r ionsv  s i te  w i thor r t  ad iuvant  ex tê rna l
beam irradiat ion of  the whole breast.
Local  t reatment for  l iver metastases
does not of fer  a solut ion for  a disease
tha t  d isseminates  haematogen ica l l y .
Only 3oolo f  the pat ients wi th color-
ectal  metastases to the l iver are sui t -
able candidates for  resect ion.  High
[ecur rence ra tes  in  and ou ts ide  the
l iver mean that adjuvant t reatment
is  necessarv  Svs temic  and rea iona l' - v ' "
chemotherapy  have pa l l ia t i ve  va lue
a lone or  lead  to  s l igh t  benef i t  in  com-
binat ion wi th surgery.  Precise target ing
of  the  rad ia t ion  beam in  new ex terna l
r a d i o t h e r a n v  ï e r - h n i a r r e s  h a s  s l . c e s S -' - ' " Y . /
fu l l y  decreased the  r i sk  o f  damage to
hea l thv  t rss r res  New loca l  and svs temic
treatment approacnes Oecame recent-
l y  ava i lab le .  A  new sys temic  t rea tment
. r n n r n : r h  i c  t h o  q ^  r : l l e r l  " l e r a o t c ' , 1q v v r v u L r  I  r J  L r  r L  J U  L U r L U  t u r v L t ( ' \ l
therapy" ;  a combina t ion  t rea tment  o f
an  an t ibody  aga ins t  ep idermal  g rowth
factor-receptor (EGF-R, cetuxi  mab) a nd
a vascular endothel ia l  growth factor
(VEGF, bevacizumab) oth in combina-
t ion  w i th  chemotherapy .  Farmacoge-
net ics  migh t  a lso  p lay  a  ro le  in  the  near
future in the select ion of  pat ients who
are candidates for  a speci f ic  chemo-
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local  (pal l iat ive) t reatment for  inoper-
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wi th  o r  w i thout  RFA,  in  case o f  marg ina l
resect ion,  combined with precise tar
ge t  rad ia t ion  t rea tment ,  as  we l l  as  the
t rse  o I  new reer iona l  o r svs ïemic  hent -
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d isease ou tcome.  The f ina l  goa l  o f  the
combined t rea tment  approaches in
the f ight  against  metastat ic olorectal
cancer  to  the  l i ver  i s  reduc ing  loca l  and
distant fa i lure and therefore improving
d isease f ree  and overa l l  surv iva l .
.H .ffi
f f i f i Summary 149
